Home › Asset managers › Compare 2025-2026 › American Century vs ProShares
American Century 2025-2026 · ProShares 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,123 | 24,929 | 1,050 | 144 | 96.0% | 95.7% |
| Board proposals | 23,824 | 22,789 | 917 | 118 | 96.1% | 95.9% |
| E&S shareholder proposals | 175 | 156 | 19 | 0 | 89.1% | 89.1% |
| Other items | 2,124 | 1,984 | 114 | 26 | 94.6% | 94.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,035 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | ProShares |
|---|---|---|---|---|---|---|
| MAINSTREET BANCSHARES, INC. | May 21, 2026 | To vote, on an advisory, non-binding basis, to approve the compensation of the named executive officers. Compensation |
Board | For | FOR 4 funds |
AGAINST 9 funds |
| MANHATTAN ASSOCIATES, INC. | May 14, 2026 | Approval of the First Amendment to Manhattan Associates, Inc. 2020 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| MANPOWERGROUP INC. | May 8, 2026 | Approval of the amendment and restatement of the Equity Incentive Plan of ManpowerGroup Inc. Compensation |
Board | For | AGAINST 8 funds |
FOR 3 funds |
| MARA HOLDINGS, INC. | June 18, 2026 | A non-binding, advisory vote on the compensation of our Named Executive Officers ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 17 funds |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | May 26, 2026 | To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| MARINE PRODUCTS CORPORATION | May 12, 2026 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of Marine Products in connection with the transactions contemplated by the merger agreement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| MARRIOTT VACATIONS WORLDWIDE CORPORATION | May 15, 2026 | Approval of the Second Amended and Restated Marriott Vacations Worldwide Corporation 2020 Equity Incentive Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 12 funds |
| MARSH & MCLENNAN COMPANIES, INC. | May 21, 2026 | Advisory (Nonbinding) Vote to Approve Named Executive Officer Compensation Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 18 funds |
| MARVELL TECHNOLOGY, INC. | June 25, 2026 | An advisory (non-binding) vote to approve compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 13 funds |
| MASIMO CORPORATION | May 1, 2026 | To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Masimo's named executive officers that is based on or otherwise relates to the Merger (the "Compensation Proposal"). Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 10 funds |
| MASTERCRAFT BOAT HOLDINGS INC | October 28, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| MATRIX SERVICE COMPANY | November 4, 2025 | Advisory vote on named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| MATTHEWS INTERNATIONAL CORPORATION | February 19, 2026 | To approve the adoption of the Second Amended and Restated 2019 Director Fee Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 13 funds |
| MAYVILLE ENGINEERING COMPANY, INC. | April 21, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| MBIA INC. | May 5, 2026 | To approve, on an advisory basis, executive compensation. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 9 funds |
| MDU RESOURCES GROUP, INC. | May 11, 2026 | Approve the Amended and Restated Long-Term Performance-Based Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| MEDIFAST, INC. | May 19, 2026 | Approve the Amended and Restated 2012 Share Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| MEDIFAST, INC. | May 19, 2026 | Approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| MERCURY SYSTEMS, INC. | October 22, 2025 | To approve our 2025 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| MESA LABORATORIES, INC. | August 22, 2025 | To approve the Amendment to the Mesa Laboratories, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 14 funds |
| MESA LABORATORIES, INC. | August 22, 2025 | To approve, on an advisory basis, the Company's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 14 funds |
| METHODE ELECTRONICS, INC. | September 17, 2025 | The advisory approval of Methode's named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| MICROSOFT CORPORATION | December 5, 2025 | Approval of the Microsoft Corporation 2026 Stock Plan Compensation |
Board | For | AGAINST 22 funds |
FOR 37 funds |
| MIDDLEFIELD BANC CORP. | February 10, 2026 | A proposal to approve, on an advisory (non-binding) basis, the merger-related consideration to be received by the named executive officers of Middlefield in connection with the Merger. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| MIDLAND STATES BANCORP, INC. | August 4, 2025 | To approve, on a non-binding, advisory basis, the compensation of certain executive officers, which we refer to as the ''say-on-pay proposal.'' Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 8 funds |
| MILLERKNOLL, INC. | October 13, 2025 | Proposal to approve the MillerKnoll, Inc. 2025 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| MIRUM PHARMACEUTICALS, INC. | June 15, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| MISTRAS GROUP, INC. | May 19, 2026 | To approve the amendment to the MISTRAS Group, Inc., 2016 Long-Term Incentive Plan to increase the number of shares authorized for issuance. Compensation |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| MITEK SYSTEMS, INC. | March 3, 2026 | Amend and restate our 2020 Incentive Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| MITEK SYSTEMS, INC. | March 3, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers as presented in the Proxy Statement accompanying this notice. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| MKS INC. | May 11, 2026 | The approval of the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| MONRO, INC. | August 12, 2025 | Approve an amendment to the Company's Amended and Restated 2007 Stock Incentive Plan to increase the number of shares available for issuance; Compensation |
Board | For | AGAINST 2 funds |
FOR 11 funds |
| MONRO, INC. | August 12, 2025 | Approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers; Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 11 funds |
| MP MATERIALS CORP. | June 9, 2026 | Advisory vote to approve compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 9 funds |
| MRC GLOBAL INC. | September 9, 2025 | Approve a non-binding advisory resolution approving the Company's named executive officer compensation Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 10 funds |
| MVB FINANCIAL CORP. | May 19, 2026 | To amend the MVB Financial Corp. 2022 Stock Incentive Plan to increase the number of shares authorized for issuance under the Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 9 funds |
| MYRIAD GENETICS, INC. | June 4, 2026 | To approve the proposed 2026 Employee, Director and Consultant Equity Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| Mama's Creations, Inc. | July 3, 2025 | To approve, on an advisory basis, the compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 4 funds |
| Meta Platforms, Inc. | May 27, 2026 | Election of Directors: Dana White Director Elections |
Board | For | WITHHOLD 25 funds |
FOR 32 funds |
| Mirion Technologies, Inc. | May 13, 2026 | Approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy statement (the "Say-on-Pay Proposal"); and Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| Monarch Casino & Resort, Inc. | May 27, 2026 | Election of Directors: John Farahi Director Elections |
Board | For | FOR 7 funds |
AGAINST 12 funds |
| N-ABLE, INC. | May 28, 2026 | Non-binding advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 14 funds |
| NABORS INDUSTRIES LTD. | June 2, 2026 | Approval of Amendment No. 5 to the Company's Amended and Restated 2016 Stock Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 10 funds |
| NATIONAL BANK HOLDINGS CORP | May 7, 2026 | To approve the proposed Amended and Restated National Bank Holdings Corporation 2023 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| NATIONAL CINEMEDIA, INC. | May 7, 2026 | To approve, on an advisory basis, our executive compensation Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| NATURE'S SUNSHINE PRODUCTS, INC. | May 6, 2026 | An advisory, non-binding resolution to approve the compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| NAVITAS SEMICONDUCTOR CORPORATION | July 8, 2025 | The approval of an advisory resolution on the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| NCR ATLEOS CORPORATION | June 30, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to NCR Atleos Corporation's named executive officers that is based on or otherwise relates to the Mergers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 15 funds |
| NEKTAR THERAPEUTICS | June 4, 2026 | To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote). Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| NEKTAR THERAPEUTICS | June 4, 2026 | To approve an amendment to our Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 3,000,000 shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| NEOGEN CORPORATION | October 23, 2025 | To Approve, On An Advisory Basis, The Compensation of Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| NEOGENOMICS, INC. | May 21, 2026 | Approval of the Second Amendment of the NeoGenomics, Inc. 2023 Equity Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 14 funds |
| NEOGENOMICS, INC. | May 21, 2026 | Approval, on a non-binding advisory basis, of the Compensation Paid to the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 14 funds |
| NETSCOUT SYSTEMS, INC. | September 10, 2025 | To approve the NetScout Systems, Inc. 2019 Equity Incentive Plan, as amended. Compensation |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| NETSCOUT SYSTEMS, INC. | September 10, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| NEUROCRINE BIOSCIENCES, INC. | May 27, 2026 | Advisory vote on the compensation paid to the Company's named executive officers; Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 10 funds |
| NEUROCRINE BIOSCIENCES, INC. | May 27, 2026 | To approve an amendment of the Company's 2025 Equity Incentive Plan to increase the aggregate number of shares of common stock reserved for issuance thereunder by 4,000,000 shares; and Compensation |
Board | For | AGAINST 10 funds |
FOR 10 funds |
| NEUROGENE INC. | June 3, 2026 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| NEW JERSEY RESOURCES CORPORATION | January 21, 2026 | To approve the 2026 Stock Award and Incentive Plan. Compensation |
Board | For | AGAINST 3 funds |
FOR 19 funds |
| NEWAMSTERDAM PHARMA COMPANY N.V. | June 2, 2026 | Non-binding, advisory vote to approve the 2025 compensation of named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| NEXTDECADE CORPORATION | June 3, 2026 | To approve, on an advisory basis, compensation of the Company's named executive officers; Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| NEXTDOOR HOLDINGS, INC | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| NEXTRACKER INC. | August 18, 2025 | The approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 13 funds |
FOR 16 funds |
| NIAGEN BIOSCIENCE, INC. | June 24, 2026 | A nonbinding advisory vote of the Company's stockholders, as recommended by the Compensation Committee and approved by the Board, on the compensation of the Company's named executive officers disclosed in the Proxy Solicitation Materials Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| NICOLET BANKSHARES, INC. | May 18, 2026 | Approval, on a non-binding advisory basis, of the compensation paid to Nicolet's named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 9 funds |
| NIKE, INC. | September 9, 2025 | To approve the NIKE, Inc. Stock Incentive Plan, as amended and restated. Compensation |
Board | For | AGAINST 9 funds |
FOR 20 funds |
| NIKE, Inc. | September 9, 2025 | Class B director nominees: To elect a Board of Directors for the ensuing year: John Rogers, Jr. Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 20 funds |
| NKARTA, INC. | June 10, 2026 | Advisory approval of the compensation paid to the company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| NORTHFIELD BANCORP, INC. | June 25, 2026 | The approval, on an advisory (non-binding) basis, of the compensation that may become payable to the named executive officers of Northfield Bancorp, Inc. in connection with the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| NORTHRIM BANCORP, INC. | May 28, 2026 | APPROVAL OF THE FIRST AMENDMENT TO THE 2025 STOCK INCENTIVE PLAN TO ADD NON-EMPLOYEE DIRECTORS TO THE CLASS OF ELIGIBLE PARTICIPANTS. To approve the First Amendment to the 2025 Stock Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| NORWEGIAN CRUISE LINE HOLDINGS LTD. | June 11, 2026 | Approval of an amendment to our 2013 Performance Incentive Plan (our "Plan"), including an increase in the number of shares available for grant under our Plan Compensation |
Board | For | AGAINST 8 funds |
FOR 21 funds |
| NOVAGOLD RESOURCES INC | May 14, 2026 | Approval of the Amendment to the Company's Stock Award Plan and the Unallocated Entitlements Thereunder - To consider and, if thought advisable, pass, with or without amendment, an ordinary resolution, approving the amendment to the Company's Stock Award Plan to reduce the maximum share reservation limit from 8% to 7% and unallocated awards, rights or other entitlements thereunder. Compensation |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| NOVOCURE LIMITED | June 3, 2026 | A non-binding advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 10 funds |
| NRG ENERGY, INC. | April 30, 2026 | To approve the NRG Energy, Inc. 2026 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 21 funds |
| NU SKIN ENTERPRISES, INC. | May 28, 2026 | Approval of our Amended and Restated 2024 Omnibus Incentive Plan Compensation |
Board | For | FOR 7 funds |
AGAINST 9 funds |
| NUTANIX, INC. | December 12, 2025 | Approval of the amendment and restatement of our 2016 Equity Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 11 funds |
| NUTANIX, INC. | December 12, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| NUTEX HEALTH INC. | April 23, 2026 | To vote in an advisory capacity concerning the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| NUVALENT, INC. | June 16, 2026 | To approve, on an advisory basis, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| NUVATION BIO INC. | May 21, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| NV5 GLOBAL, INC. | July 31, 2025 | To approve, on a non-binding, advisory basis, the compensation that will or may be paid to NV5's named executive officers in connection with the transactions contemplated by the Merger Agreement; and. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 13 funds |
| NVE CORPORATION | August 7, 2025 | Advisory approval of named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| NioCorp Developments Ltd. | April 6, 2026 | Advisory Vote to Approve Named Executive Officer Compensation To approve, on a nonbinding, advisory basis, the compensation of the Company's named executive officers as described in the Company's Management Information and Proxy Circular in respect of the annual general meeting of shareholders of the Company held on April 6, 2026. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 9 funds |
| NorthWestern Energy Group, Inc. | April 2, 2026 | To vote on an advisory vote on the merger-related compensation arrangements of NorthWestern's named executive officers (the "NorthWestern Merger-Related Compensation Proposal"); and Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 22 funds |
| NovaGold Resources Inc. | May 14, 2026 | Approval of All Unallocated Awards under the Performance Share Unit Plan To consider and, if thought advisable, pass, with or without amendment, an ordinary resolution, approving unallocated awards, rights or other entitlements under the Company's Performance Share Unit Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| Nurix Therapeutics, Inc. | May 15, 2026 | To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| OCTAVE SPECIALTY GROUP, INC. | May 28, 2026 | To approve, on a non-binding advisory basis, the compensation for our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| OLD NATIONAL BANCORP | May 13, 2026 | Approval of the Company's 2026 Equity Compensation Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 18 funds |
| OLEMA PHARMACEUTICALS, INC. | June 17, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| OLIN CORPORATION | April 30, 2026 | Approval of Olin Corporation 2026 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| OLO INC. | September 9, 2025 | Approval of, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Olo's named executive officers in connection with the Merger. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| OMEROS CORPORATION | June 18, 2026 | Approval of advisory resolution on executive compensation. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 12 funds |
| OMNICELL, INC. | May 19, 2026 | Proposal to approve an amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 1,600,000 shares to the number of shares of common stock authorized for issuance under such plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| OMNICOM GROUP INC. | January 28, 2026 | Approval of the Omnicom 2026 Incentive Award Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 19 funds |
| OMNICOM GROUP INC. | May 5, 2026 | Advisory resolution to approve executive compensation. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 19 funds |
| ONESPAN INC. | June 5, 2026 | To approve an amendment of the Company's Amended and Restated 2019 Omnibus Incentive Plan to increase available shares thereunder by 2,000,000 shares; and Compensation |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ONESPAWORLD HOLDINGS LIMITED | June 3, 2026 | Approval of the OneSpaWorld Holdings Limited Amended and Restated 2019 Equity Incentive Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| ONEWATER MARINE INC. | February 19, 2026 | Approval of, on an advisory (non-binding) basis, the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| ORASURE TECHNOLOGIES, INC. | June 3, 2026 | To approve an amendment and restatement of the Company's Stock Award Plan to increase the number of shares of Common Stock authorized to be granted under the Plan by 5,000,000 shares and extend its term by an additional ten years. Compensation |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| ORASURE TECHNOLOGIES, INC. | June 3, 2026 | To approve, by an advisory (non-binding) vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
← Previous Page 6 of 11 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.